[Chemotherapy of vaginal trichomoniasis and candidiasis in mice].
D000284:Administration, Oral; D000287:Administration, Topical; D000666:Amphotericin B / Q000627:therapeutic use*; D000818:Animals; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002175:Candida / Q000187:drug effects; D002176:Candida albicans / Q000187:drug effects; D002177:Candidiasis / Q000188:drug therapy*; D006224:Cricetinae; D004353:Drug Evaluation, Preclinical; D005260:Female; D006168:Guinea Pigs; D006582:Hexachlorophene / Q000627:therapeutic use; D051379:Mice; D010866:Natamycin / Q000627:therapeutic use*; D009761:Nystatin / Q000627:therapeutic use; D051381:Rats; D013752:Tetracycline / Q000627:therapeutic use; D014245:Trichomonas Infections / Q000188:drug therapy; D014247:Trichomonas Vaginitis / Q000188:drug therapy*; D014246:Trichomonas vaginalis / Q000187:drug effects; D014627:Vaginitis / Q000188:drug therapy*
D000935:Antifungal Agents; D009761:Nystatin; D000666:Amphotericin B; D010866:Natamycin; D013752:Tetracycline; D006582:Hexachlorophene
Die Chemotherapie der vaginalen Trichomoniasis und Candidosis der Maus